imipramine has been researched along with Alloxan Diabetes in 8 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with imipramine decreased the immobility time in nondiabetic and diabetic rats, compared with both nondiabetic and diabetic rats treated with saline." | 1.38 | Imipramine treatment reverses depressive-like behavior in alloxan-diabetic rats. ( Aguiar, BW; Ceretta, LB; Kapczinski, F; Lersh, C; Pfaffenseller, B; Quevedo, J; Réus, GZ; Ribeiro, KF; Stringari, RB; Zappellini, G, 2012) |
"Depression is highly prevalent in diabetics and is associated with poor glucose regulation and increased risk of diabetic complications." | 1.32 | Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice. ( Anjaneyulu, M; Chopra, K; Kaur, I, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Rahmani, G | 1 |
Farajdokht, F | 1 |
Mohaddes, G | 1 |
Babri, S | 1 |
Ebrahimi, V | 1 |
Ebrahimi, H | 1 |
Habib, M | 1 |
Shaker, S | 1 |
El-Gayar, N | 1 |
Aboul-Fotouh, S | 1 |
Nadeem, RI | 1 |
Ahmed, HI | 1 |
El-Denshary, EE | 1 |
Ceretta, LB | 1 |
Réus, GZ | 1 |
Stringari, RB | 1 |
Ribeiro, KF | 1 |
Zappellini, G | 1 |
Aguiar, BW | 1 |
Pfaffenseller, B | 1 |
Lersh, C | 1 |
Kapczinski, F | 1 |
Quevedo, J | 1 |
Anjaneyulu, M | 1 |
Chopra, K | 1 |
Kaur, I | 1 |
Massol, J | 3 |
Martin, P | 3 |
Chatelain, F | 2 |
Puech, AJ | 3 |
Belon, JP | 1 |
Soubrié, P | 2 |
8 other studies available for imipramine and Alloxan Diabetes
Article | Year |
---|---|
Garlic (
Topics: Animals; Antidepressive Agents; Antioxidants; Anxiety; Brain; Depressive Disorder; Diabetes Mellitus | 2020 |
The effects of antidepressants "fluoxetine and imipramine" on vascular abnormalities and Toll like receptor-4 expression in diabetic and non-diabetic rats exposed to chronic stress.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Blood Glucose; Blood Pressure; Blood Vessels; Body | 2015 |
Effect of Imipramine, Paroxetine, and Lithium Carbonate on Neurobehavioral Changes of Streptozotocin in Rats: Impact on Glycogen Synthase Kinase-3 and Blood Glucose Level.
Topics: Animals; Behavior, Animal; Blood Glucose; Diabetes Mellitus, Experimental; Glycogen Synthase Kinase | 2015 |
Imipramine treatment reverses depressive-like behavior in alloxan-diabetic rats.
Topics: Alloxan; Amygdala; Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Fact | 2012 |
Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice.
Topics: Animals; Antidepressive Agents; Depression; Diabetes Mellitus, Experimental; Disease Models, Animal; | 2003 |
Tricyclic antidepressants, thyroid function, and their relationship with the behavioral responses in rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Arousal; Avoidance Learning; Clomipramine; Conditioning, | 1990 |
Helpless behavior (escape deficits) in streptozotocin-diabetic rats: resistance to antidepressant drugs.
Topics: Animals; Antidepressive Agents; Brain; Clenbuterol; Clomipramine; Conditioning, Operant; Desipramine | 1989 |
Impaired response of experimental diabetic mice to tricyclics: a possible beta-adrenergic mechanism.
Topics: Animals; Clenbuterol; Clomipramine; Desipramine; Diabetes Mellitus, Experimental; Dose-Response Rela | 1988 |